The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ICU Medical's revenues will increase 8.2% and EPS will contract -37.3%.
The average estimate for revenue is $82.7 million. On the bottom line, the average EPS estimate is $0.79.
Last quarter, ICU Medical logged revenue of $81.4 million. GAAP reported sales were 6.5% higher than the prior-year quarter's $76.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.82. GAAP EPS of $0.82 for Q3 were 26% higher than the prior-year quarter's $0.65 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 50.0%, 350 basis points better than the prior-year quarter. Operating margin was 21.5%, 410 basis points better than the prior-year quarter. Net margin was 15.0%, 290 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $316.9 million. The average EPS estimate is $2.77.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 85 members out of 98 rating the stock outperform, and 13 members rating it underperform. Among 29 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 27 give ICU Medical a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ICU Medical is outperform, with an average price target of $62.50.
Is ICU Medical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add ICU Medical to My Watchlist.